Circulatory Support Devices Market – Shortage of Donors and Improved Survival Rate to Drive Growth | Technavio

11-Nov-2017 Intellasia | BusinessWire | 12:23 AM Print This Post

LONDON–(BUSINESS WIRE)–#CardiovascularDevices–According to the latest market study released by Technavio,
the global circulatory support devices market is expected to grow at a
CAGR of more than 11% during the forecast period.


This research report titled ‘Global
Circulatory Support Devices Market 2017-2021
’ provides an in-depth
analysis of the market in terms of revenue and emerging market trends.
This report also includes an up to date analysis and forecasts for
various market segments and all geographical regions.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2
Technavio reports and get the third for free.

The market research analysis categorizes the global circulatory support
devices market into three major product segments:

  • Ventricular assisted device (VAD)
  • Extracorporeal membrane oxygenation (ECMO)
  • Total artificial heart (TAH)

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report including the market size and forecast, drivers,
challenges, trends, and more.

Global VAD market

The global VAD market is growing at a significant rate owing to its
cost-effectiveness when compared to heart transplantation. Shortage of
donors and improved survival rate are the major factors driving the
demand for these supporting devices. VAD will provide aid to the heart
but not completely replace heart activities. Also, the advances in
technology in terms of design are playing a key role in higher adoption
of VAD in developed countries. The growing number of patients with
congestive heart failure (IV stage) is another main factor driving the
sales of VADs in the global circulatory
support devices market
. Moreover, advances in technology have led to
the development of new generation LVADs, which are small, less noisy,
and durable with enhanced power sources.

Global ECMO market

The global ECMO market is expected to grow at a moderate rate owing to
the growing incidence of cardiovascular disorders, respiratory
disorders, and the growing geriatric population. In addition, the
outspread application of ECMO is driving the demand through various
application segments such as cardiac, respiratory, and extracorporeal
cardiopulmonary resuscitation (ECPR).

“In addition, a significant rise in ECMO centers, rising awareness
through conferences and training programs, and the advances in
technology are significant factors driving the demand for ECMO
supporting devices during the forecast period. Also, the growing older
population in APAC and a significant number of people with
cardiopulmonary diseases in developing nations such as China and India
are expected to provide the potential growth opportunity for ECMO
devices,”
says Barath Palada, a lead analyst at Technavio for cardiovascular
devices
research.

Global TAH market

The global TAH market is growing at a faster rate compared with other
circulatory assist devices globally. Europe is the leading revenue
contributor to the global TAH market, followed by the Americas and APAC.
Europe dominates the market, as the device got European Medicines Agency
(EMA) approval before the US FDA approval and had early adoption
advantage for the end-users.

The market for TAH is expected to benefit from the fact that it is the
only option, which can provide a permanent solution in the absence of a
donor’s heart. The TAH is gaining popularity among critically ill
patients, who are in life-threatening condition due to extreme
malfunction of their heart. The TAH will enhance the life expectancy of
people with end-stage heart failure and extend the life expectancy over
months compared with the other circulatory support devices.

The top vendors highlighted by Technavio’s market research analysts in
this report are:

  • Medtronic
  • St. Jude Medical
  • ABIOMED
  • ReliantHeart
  • Berlin Heart

Browse Related Reports:

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

 


Category: BusinessWire, PRAsia

Print This Post